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TubulinThe small GTPase Arl6 is implicated in the ciliopathic human genetic disorder Bardet–Biedl syndrome, acting
at primary cilia in recruitment of the octomeric BBSome complex, which is required for speciﬁc trafﬁcking
events to and from the cilium in eukaryotes. Here we describe functional characterisation of Arl6 in the ﬂag-
ellated model eukaryote Trypanosoma brucei, which requires motility for viability. Unlike human Arl6 which
has a ciliary localisation, TbARL6 is associated with electron-dense vesicles throughout the cell body follow-
ing co-translational modiﬁcation by N-myristoylation. Similar to the related protein ARL-3A in T. brucei, mod-
ulation of expression of ARL6 by RNA interference does not prevent motility but causes a signiﬁcant reduction
in ﬂagellum length. Tubulin is identiﬁed as an ARL6 interacting partner, suggesting that ARL6 may act as an
anchor between vesicles and cytoplasmic microtubules. We provide evidence that the interaction between
ARL6 and the BBSome is conserved in unicellular eukaryotes. Overexpression of BBS1 leads to translocation
of endogenous ARL6 to the site of exogenous BBS1 at the ﬂagellar pocket. Furthermore, a combination of
BBS1 overexpression and ARL6 RNAi has a synergistic inhibitory effect on cell growth. Our ﬁndings indicate
that ARL6 in trypanosomes contributes to ﬂagellum biogenesis, most likely through an interaction with the
BBSome.
© 2012 Elsevier B.V. Open access under CC BY license. 1. Introduction
The Arf-like (Arl) proteins are a subfamily of the Arf small GTPases,
with diverse roles in vesicle trafﬁcking [1], tubulin folding andmicrotu-
bule dynamics [2], endosome–lysosome fusion [3] and ciliogenesis [4].
While the functions and effectors of the closely related Arf proteins
have been extensively characterised, much less is known about Arl pro-
tein interactions and their regulation of fundamental processes within
the eukaryotic cell.-ribosylation factor-like; Arl6ip,
BS1, Bardet–Biedl syndrome 1
F, guanine nucleotide exchange
etinal gene 4; IFT, intraﬂagellar
N-methylanthraniloyl; MAP2,
ignal; NLS, nuclear localisation
se; PCF, procyclic form; PCM1,
lasma membrane; RNAi, RNA
, tandem afﬁnity puriﬁcation;
+44 1904 328844.
 license. Human Arl6 is encoded by Bbs3, one of 14 genes in whichmutations
are implicated in the autosomal recessive clinical disorder Bardet–Biedl
syndrome (BBS) [5–7]. The pleiotrophic features of this condition
include retinal degeneration, renal abnormalities, polydactyly, obesity,
mental retardation and hypogenitalism, many of which are consistent
with cilium dysfunction. Comparative genomic analysis has shown that
orthologues of Arl6 and the other BBS-associated genes are restricted
to ciliated and ﬂagellated organisms, and are absent from species which
use ﬂagella only for motility of gametes or zoospores e.g. Plasmodium
falciparum [7–9]. Expression of Arl6 in Caenorhabditis elegans is upreg-
ulated in ciliated cells in which the protein is trafﬁcked by intraﬂagellar
transport (IFT) [10]. Recent evidence has shown that GTP-bound human
Arl6 can bind BBS1, a subunit of the BBSome complex, andmay act in re-
cruitment of this complex to the primary cilium [11]. The BBSome is a sta-
ble octomeric complex comprised of 7 Bardet–Biedl syndrome associated
proteins (BBS1, 2, 4, 5, 7, 8 and 9) plus a novel protein BBIP10 [12,13]. The
exact molecular mechanisms regulated by this complex remain largely
unknown but there are marked similarities between the predicted struc-
tures of the BBSome components and those of the subunits of the COPII
and clathrin cages, indicating a possible function of the BBSome as a
coat complex [11]. Further, a recent report indicates that the BBSome
1179H.P. Price et al. / Biochimica et Biophysica Acta 1823 (2012) 1178–1191subunit BBS7 localises transiently to the nucleus where it binds to the
polycomb protein RNF2 and may have a direct role in transcriptional
regulation [14].
The BBSome in C. elegans appears to mediate the IFT machinery, as
loss-of-function mutations in Bbs7 and Bbs8 orthologues cause abnor-
malities in localisation and motility of two IFT proteins, OSM-5/
Polaris/IFT88 and CHE-11, resulting in truncated cilia and inhibition
of chemotaxis [15]. However, in the majority of systems studied to
date, the BBSome is believed to be required for speciﬁc trafﬁcking
events to and from the cilium rather than for ciliogenesis. Two G-
protein coupled receptors (GPCR), somatostatin receptor 3 and
melanin-concentrating hormone receptor 1, fail to localise to the cil-
ium of hippocampal neurons in BBSome knockout strains of mice
[16]. In contrast, the GPCR dopamine receptor 1, which normally
shuttles to and from cilia, can still be trafﬁcked to neuronal cilia in
Bbs2 and Bbs4 null mice but fails to exit the cilium in response to re-
ceptor ligand in these animals [17]. Insertional mutants of Bbs1, Bbs4
or Bbs7 in the green alga Chlamydomonas reinhardtii produce normal
length ﬂagella but phototaxis is disrupted due to a defect in retro-
grade transport from the ﬂagellum leading to accumulation of signal-
ling proteins [18]. No reports have been published to date on the
functions of the BBSome or associated proteins in parasitic protozoa
or any other pathogenic organisms.
Here we describe functional characterisation of Arl6 in the parasitic
protozoan Trypanosoma brucei, as part of a comprehensive study of ARF/
ARL proteins as substrates of the validated drug target myristoyl-CoA:
protein N-myristoyltransferase (NMT) [19–22]. We provide experi-
mental evidence that T. brucei ARL6 is N-myristoylated as predicted by
protein sequence analysis. The trypanosome orthologue of Arl6 is
found on small electron-dense vesicles throughout the parasite body.
The protein is able to associate with tubulin and might therefore act
as a link between the BBSome complex and the intracellular microtu-
bule network. Knockdown of TbARL6 is not lethal to the parasite but
causes a signiﬁcant decrease in ﬂagellum length, perhaps indicative of
defects in protein trafﬁcking to the ﬂagellum. This observation suggests
a degree of evolutionary conservation in the role of this protein and pos-
sibly of the BBSome complex in trypanosomes.
2. Materials and methods
2.1. DNA constructs
All primer sequences are provided in Supplementary Table 1. For
protein expression in Escherichia coli, a fragment spanning nucleo-
tides 1–570 of the TbARL6 (TriTrypDB ID: Tb927.8.5060) open read-
ing frame was ampliﬁed from genomic DNA using primers ARL6-F1
and ARL6-R1 and cloned into plasmid vector pET-YSBLIC3C (pET28a
modiﬁed for ligation-independent cloning) [23,24] to produce the
construct pET-HisARL6. For tetracycline-inducible overexpression of
C-terminal myc-tagged TbARL6 and N-terminal myc-tagged BBS1
(TriTrypDB ID: Tb09.211.2080) in bloodstream form T. brucei, the
open reading frames were ampliﬁed from genomic DNA using
primers ARL6-F2 and ARL6-R2 or BBS1-F1 and BBS1-R1. The products
were ligated into plasmid vectors pT7-MYC-C or pT7-MYC-N [22,25];
(obtained from David Horn and Sam Alsford, London School of Hy-
giene and Tropical Medicine, London, UK) to produce the constructs
pTbARL6MYC and pTbMYCBBS1. Mutations were introduced into
pTbARL6MYC using the GeneTailor Site-Directed Mutagenesis System
(Invitrogen) and primers ARL6-F3 and ARL6-R3 (G2A) or ARL6-F4
and ARL6-R4 (T21N) to produce the constructs pTbARL6-G2AMYC
and pTbARL6-T21NMYC. For RNA interference, a region spanning nu-
cleotides 48–362 of the T. brucei ARL6 open reading frame was ampli-
ﬁed from genomic DNA using the primers ARL6-F5 and ARL6-R5. The
product was digested with XbaI and ligated into XbaI-digested plasmid
vector p2T7Ti (a gift from Doug LaCount, PULSe, Purdue University,
West Lafayette, IN, USA) to produce the construct p2T7ARL6. For PTPtagging, the ARL6 open reading frame was ampliﬁed from T. brucei
genomic DNA using primers ARL6-F6 and ARL6-R6, digested with
ApaI/NotI and ligated into digested pC-PTP-NEO (a gift from Arthur
Günzl, Department of Genetics and Developmental Biology, University
of Connecticut Health Center, Farmington, CT, USA) to produce the
construct pTbARL6PTP.
2.2. Production of recombinant TbARL6 in E. coli
The construct pET-HisARL6 was introduced into E. coli BL21 star
and expression of recombinant protein induced with 1 mM IPTG for
4 h at 30 °C. For large-scale protein puriﬁcation, cells from 5 l of cul-
ture were resuspended in 100 ml lysis buffer (300 mM NaCl, 20 mM
sodium phosphate pH 7.4, 40 mM imidazole and 1× complete protease
inhibitor cocktail, Roche). Cells were lysed by three rounds of sonication
then centrifuged at 50,000 g for 40 min at 15 °C. Protein puriﬁcation
was performed using Ni2+-afﬁnity/size exclusion multi-dimensional
liquid chromatography on an ÄKTA Express (GE Healthcare). The
clariﬁed lysate was applied at 1 ml/min to a ﬁrst stage afﬁnity-
chromatography column (1 ml HisTrap FF, GE Healthcare) equili-
brated in 20 mM sodium phosphate, pH 7.5, 300 mM NaCl and
20 mM Imidazole (Buffer A), before removal of non-speciﬁcally
bound proteins with 20 column volumes of Buffer A. His-tagged pro-
teins were removed using an isocratic gradient of Buffer A containing
0.5 M imidazole (Buffer B) and the UV280 nm absorbing material was
peak-fractionated and collected into a system sample loop. The con-
tents of the sample loop were subsequently applied at 1 ml/min to a
second stage size exclusion-chromatography column (Superdex200
16/60, GE Healthcare) equilibrated in 20 mM sodium phosphate,
pH 7.5, 150 mM NaCl (Buffer C) and then eluted using a 1.2 column
volume isocratic gradient of Buffer C. Fractions (1.8 ml) of UV280 nm
absorbing material were collected and analysed for speciﬁc protein
content by SDS-PAGE.
2.3. Antibody production
Polyclonal antibodieswere produced from two rabbits (Eurogentech,
87 day Classic protocol). Antibodies were puriﬁed using a 1 ml NHS-
activated HP column (GE) coupled to 5 mg of recombinant TbArl6 pro-
tein. Following column equilibration with 10 ml binding buffer (20 mM
sodium phosphate pH 7 and 150 mM NaCl), 15 ml rabbit serum was
loaded onto the column at 0.3 ml/min. Unbound sample was removed
with a 5 ml wash with binding buffer. Elution was then performed
using elution buffer at low pH (0.1 M glycine pH 2.7 and 0.5 M NaCl).
Fractions of 0.5 ml were collected directly into tubes containing 50 μl
1 M Tris–HCl pH 9.0 and analysed by SDS‐PAGE. Peak fractions were
pooled and tested by immunoblotting.
2.4. Parasite culture
The T. brucei brucei BSF strain Lister 427 was maintained in vitro at
37 °C with 5% CO2 in HMI-9 medium containing 2 μg/ml Geneticin
(Invitrogen) as described [26]. The T. brucei brucei procyclic strain
449 was maintained in vitro at 26 °C in SDM-79 medium containing
25 μg/ml phleomycin [26]. All culture media contained 10% tetracycline-
free fetal bovine serum (Autogen Bioclear).
2.5. Protein analysis
Immunoblotting of total parasite lysateswas performed as described
previously [22,27]. Primary antibodies used were: rabbit anti-TbARL6
(1:500 dilution); rabbit anti-TbNMT [19] (1:500 dilution); mouse
anti-myc (1:2000 dilution, Invitrogen); and mouse monoclonal L13D6
against PFR1/2 (1:500 dilution, a gift from Keith Gull, Sir William
Dunn School of Pathology, University of Oxford, UK). For subcellular
fractionation, parasites were centrifuged at 800 g for 10 min at 20 °C,
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containing (P100) fractions, cells were subjected to hypotonic lysis on
ice for 1 h in 10 mMTris pH 7.5 containing 1× Complete protease inhib-
itor cocktail (Roche), 7.5 μMPepstatin A and 5 μME-64d. Samples were
centrifuged at 100,000 g for 30 min at 4 °C, then supernatant (S100)
and pellet (P100) fractions stored in Laemmli buffer. Previous studies
have shown that T. brucei cytoskeletal and ﬂagellar fractions can be
obtained by subjecting cells to detergent/NaCl extraction [27,28]. Para-
sites were resuspended in PEME (100 mM PIPES, 2 mM EGTA, 0.1 mM
EDTA and 1 mM MgSO4, pH 6.9) containing 1% Nonidet P40, 1× Com-
plete protease inhibitor cocktail (Roche), 7.5 μM Pepstatin A and 5 μM
E-64d, incubated on ice for 10 min, then centrifuged at 15,000 g
for 15 min at 4 °C. Pellets were either washed twice in PEME and
resuspended in Laemmli buffer (NP40-insoluble fraction containing
cytoskeleton) or further extracted in PEME containing 1 M NaCl,
200 μg/ml DNaseI, 50 μg/ml RNaseA and protease inhibitors as above.
Samples were incubated on ice for 10 min, centrifuged as above, salt
extraction repeated once, then pellets washed twice in PEME. Pellets
were resuspended in Laemmli buffer (NP40/1 M NaCl-insoluble frac-
tion containing ﬂagella). Total cell lysates and subcellular fractions
from the equivalent of 1×107 cells per sample were analysed by im-
munoblotting and probed with antibodies as above.
2.6. Myristate tagging and ﬂuorescent labelling of TbARL6
Parasites were metabolically labelled by the addition of 100 μM
myristic acid or the myristate analogue YnC12 [29] to T. brucei BSF
(1×106/ml in HMI-9) or PCF (5×106/ml in SDM-79). Cells were
then grown for 8 h at 37 °C with 5% CO2 (BSF) or 18 h at 26 °C (PCF)
before harvesting. Parasites were lysed in ice-cold RIPA buffer
(50 mM Tris pH 7.4, 1% (v/v) NP-40, 1% (w/v) sodium deoxycholate,
150 mM NaCl, 0.5% (w/v) SDS and 1× Complete protease inhibitor
cocktail (Roche)), sonicated, then centrifuged at 15,000 g for 30 min
at 4 °C. Lysate protein concentrations were determined by the DC
protein assay (BioRad). Protein lysates (0.5 mg total protein) from
myristate-labelled and YnC12-labelled cells were incubated with
10 μl of anti-TbARL6 with rotation overnight at 4 °C. Approximately
30 μl packed Fast Flow Protein A Sepharose beads (GE Healthcare)
were added and the lysates rotated for 2 h at 4 °C. Beads were washed
twice with ice-cold RIPA buffer, twice with 0.1% (w/v) SDS/PBS then
resuspended in 50 μl PBS for on-bead click labelling. Click reagents
(TAMRA-capture reagent Az-TB, CuSO4, TCEP and TBTA) were pre-
pared and premixed as described previously [29], added to the
beads and left on ice with occasional gentle vortexing for 90 min.
SDS was added to a ﬁnal concentration of 2% and the beads heated
for 10 min at 95 °C. The solution was removed and the proteins pre-
cipitated (CHCl3/MeOH), then resuspended in 1× sample loading
buffer with beta-mercaptoethanol (NuPAGE LDS sample buffer) for
gel and blot analysis.
Samples were separated by SDS-PAGE and the gel washed brieﬂy
in water for in-gel ﬂuorescent imaging. Gels were scanned with Cy3
ﬁlters to detect the TAMRA ﬂuorophore using an Ettan DIGE scanner
(GE Healthcare). Proteinswere transferred to PVDFmembrane, blocked
(5% milk in TBS 0.1% Tween-20, 40 min at room temperature), washed,
and reimaged for ﬂuorescent signal. Themembranewas then incubated
with anti-TbARL6 (1:300 in blocking solution) for 90 min, then probed
with goat anti-rabbit-HRP secondary (Invitrogen) (1:5000 in blocking
solution) for 30 min. Proteins were visualisedwith Luminata Crescendo
Western HRP substrate (Millipore).
2.7. Microscopy
Indirect immunoﬂuorescence assays were performed as described
[22] using rabbit anti-TbARL6 (1:100, described in Section 2.3), mouse
monoclonal antibody TAT1 against T. brucei α-tubulin (1:200, a gift
from Keith Gull, as in Section 2.5), mouse monoclonal L13D6 (as inSection 2.5, 1:50), rabbit anti-TbRab5A (1:250, a gift from Mark Field,
Department of Pathology, University of Cambridge, UK) and mouse
anti-myc (1:250, Invitrogen) with detection using Alexa Fluor 488 and
594 conjugated secondary antibodies (Invitrogen). Staining with FM4-
64FX (Invitrogen) and Alexa Fluor 488-conjugated ConA (Invitrogen)
were performed as described previously [21,22]. Samples were
visualised by confocal microscopy as described previously [21].
Transmission electron microscopy was performed as described
[30]. For transmission immuno-electron microscopy, BSF cells in cul-
ture mediumwere diluted in a 1:1 ratio with 8% formaldehyde (w/v)/
0.4% glutaraldehyde (w/v) in 100 mM sodium phosphate and incu-
bated for 15 min. Following centrifugation, cells were sequentially
treated with 4% formaldehyde (w/v)/0.2% glutaraldehyde (w/v) in
100 mM sodium phosphate buffer for 15 min, 0.1% glycine (w/v) in
100 mM PBS for 20 min, then in 1% gelatin in pure water for 30 min.
Cells were then treated with 10% gelatin in pure water and the cell
pellet spun down, cut into pieces and infused with 2.3 M sucrose in
PBS overnight at 4 °C. Samples were mounted on Leica cryo-holders
and frozen in liquid nitrogen before sectioning (approximately
90 nm thickness) on a Leica Ultracut with cryochamber. Sections
were transferred to copper grids, then inverted onto drops of liquid
on paraﬁlm for immunogold labelling. The grids were incubated in
50 mM glycine/PBS for 5 min, in blocking solution (10% goat serum/
PBS) for 20 min, then in primary antibody (rabbit anti-TbARL6 as in
Section 2.3 or mouse anti-myc, Invitrogen) diluted 1:25 in blocking
solution for 1 h. Samples were washed ﬁve times in blocking buffer,
then incubated in 10 nM gold conjugated goat anti-rabbit or anti-
mouse IgG (Agar Scientiﬁc) diluted 1:10–1:40 in blocking buffer for
45 min, then washed ﬁve times in blocking buffer. Cells were then
ﬁxed in 1% glutaraldehyde in 100 mM sodium phosphate buffer for
10 min and washed ﬁve times in pure water. Samples were incubated
with 2%methyl cellulose/0.4% uranyl acetate on paraﬁlm placed on an
ice-chilled metal block in the dark for 10 min. Viewing was at 120 kV
with a Tecnai 12 BioTwin (FEI) and images were captured with a SIS
Megaview III digital camera.
2.8. Expression of myc-tagged ARL6 and BBS1
The constructs pTbARL6MYC, pTbARL6-G2AMYC, pTbARL6-T21NMYC
and pTbMYCBBS1 (NotI digested) were transfected into mid-log phase
T. brucei BSF Lister 427 using the Nucleofector® system as described
[31] and transformants selected with 10 μg/ml hygromycin. Expres-
sion of tagged protein was induced in stable cell lines by incubating
parasites in 1 μg/ml tetracycline for 24 h. Parasite growth was analysed
using a Beckman Coulter counter.
2.9. RNA interference of ARL6
The construct p2T7ARL6 (NotI digested) was transfected into
mid-log T. brucei BSF Lister 427 by nucleofection as in Section 2.7
and transformants selected with 2.5 μg/ml phleomycin. Production
of TbARL6-speciﬁc double-stranded RNA was induced by incubating
stable cell lines in 1 μg/ml tetracycline for 24 h. Knockdown of ARL6
expression was monitored by immunoblotting with anti-TbARL6
antibody. Stable ARL6 RNAi cell lines were also transfected with
NotI digested pTbMYCBBS1, transformants selected by the addition of
10 μg/ml hygromycin and cell lines analysed as in Section 2.7. Cell
body and paraﬂagellar rod (PFR) lengths were analysed by performing
indirect immunoﬂuorescence on cells treated with 1% Triton X-100 at
room temperature for 5 min before staining with mouse monoclonal
L13D6 or TAT1 (as in Section 2.6) and detection using Alexa Fluor
488-conjugated goat anti-mouse IgG and IgM (Invitrogen). Cell body
(posterior end of the body to the ﬂagellum tip) and PFR lengths (100
per sample) were measured from acquired images using LSM 510
version 3.2 software (Zeiss). Statistical analysis (1 way ANOVA) was
performed using GraphPad Prism 4.
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Swiss outbred (CD-1) mice were infected by i.p. injection with
2×105 parasites of the parental or TbARL6 RNAi lines as in
Section 2.8, grown in the absence or presence of tetracycline for 4 h
prior to infection. Mice given tetracycline-treated cells were given
doxycycline in drinking water. Parasitaemia was measured at 48 h
and 72 h by microscopy analysis of tail-cut blood samples and
the experiment terminated at the later timepoint.
2.11. Tandem afﬁnity puriﬁcation
Log phase T. brucei procyclic strain 449 cells were transfected with
BsmI-digested pTbARL6PTP by nucleofection as in Section 2.7, replacing
one endogenous allele of ARL6 with a C-terminal PTP tagged copy
of the ARL6 open reading frame. Transformants were selected with
25 μg/ml hygromycin. Once stable cell lines had been established, tan-
dem afﬁnity chromatography was performed as described previously
[32]. Brieﬂy, a crude extract was prepared from 9 l of culture (approxi-
mating 1×1011 cells) by resuspension of cells in 15 ml of lysis buffer
(150 mM sucrose, 150 mM KCl, 20 mM potassium glutamate, 20 mM
Hepes–KOH pH 7.7, 3 mM MgCl2, 10 mg/ml leupeptin, and 0.5% DTT)
and passaging through a French press at 4 °C. The lysate was subjected
to IgG afﬁnity chromatography and bound complexes were eluted
by incubation with AcTEV protease. The eluate was then subjected
to anti-ProtC afﬁnity chromatography. Proteins were eluted by the
addition of EGTA/EDTA to inhibit calcium-dependent binding. The
ﬁnal eluate was concentrated by binding to 10 μl of hydrophobic
StrataClean resin (Stratagene) then released into Laemmli SDS-PAGE
loading buffer. Samples were separated by SDS-PAGE and stained
with Coomassie. Protein bands were excised and identiﬁed by MS/MS
analysis of trypsin digests on a 4700 Proteomics Analyser (Applied
Biosystems). The mass spectral data were submitted to database
searching against the NCBInr database using a locally running copy of
the Mascot software (Matrix Science) through a GPS Explorer (Applied
Biosystems) interface. The data shown are representative of 4 indepen-
dent biological replicates.
2.12. Tubulin overlay assay
Overlay assays were performed as described [33] using TbARL6
recombinant protein (described in Section 2.2) and negative controls:
recombinant human Ras (R9894, Sigma) and bovine serum albumin
(New England Biolabs). Proteins (1 μg per lane) were subjected to
SDS-PAGE and transferred to nitrocellulose. A duplicate gel was stained
with Coomassie Blue. Blots were incubated in TBS/1% Tween-20 for
45 min at room temperature, then in 8 μg/ml porcine tubulin (Sigma)
in TBS/0.2% Tween-20 overnight at 4 °C. Blots were washed in TBS/
0.2% Tween-20, blocked in 5% milk/TBS/0.2% Tween-20 and probed
with mouse monoclonal antibody TAT1 (α-tubulin, 1:10,000 dilution),
mouse monoclonal clone 6-11B-1 (acetylatedα-tubulin, 1:10,000 dilu-
tion, Sigma) or mouse monoclonal TUB 2.1 (β-tubulin, 1:1000, Sigma).
2.13. Microtubule binding assay
In order to determine if TbARL6 was able to bind to microtubules
in vitro, a Microtubule Binding Protein Spin-Down Assay kit (Cyto-
skeleton, Inc.) was used, following the manufacturer's instructions.
All buffers containing polymerised tubulin were supplemented with
20 μM Taxol. Brieﬂy, 2.5 μg of pure TbARL6 protein was incubated
for 30 min at room temperature with a suspension of freshly poly-
merised microtubules (equivalent of 2 μM of tubulin dimer) in the
presence of 10 mM MgCl2 and 4 mM GDP or GTP. Control samples
were also prepared using 2.5 μg of MAP2 or BSA instead of TbARL6,
or with the omission of either the test protein or microtubules from
the reaction mix. Following incubation, samples were placed onto alayer of Cushion Buffer (80 mM PIPES, pH 7.0, 2 mM MgCl2, 1 mM
EGTA, and 60% glycerol) and centrifuged at 100,000 g for 40 min.
The uppermost layer of supernatant (soluble fraction) and pellet
(insoluble fraction) were subjected to SDS-PAGE and stained with
Coomassie Blue. In addition, the effects of TbARL6 on tubulin poly-
merisation in vitrowere analysed by measuring turbidity as described
previously [34].
2.14. Fluorescence spectroscopy
All samples were diluted in 50 mM KHPO4 (pH 7.4), with 10 mM
MgCl2 and 12.5 μm unlabelled GDP/GTP (Sigma) or 5 μM N-met-
hylanthranil acid (mant) labelled GDP/GTP (Invitrogen).Measurements
were recorded on a Fluoromax-4 spectrophotometer (Horiba Jobin-
Yvon Ltd, Stanmore, UK). Tryptophan ﬂuorescence spectra (5 μM pro-
tein) were measured at an excitation of 278 nm and emission range of
300–450 nm.Mant ﬂuorescence spectra were measured at an excitation
of 350 nm and emission range of 350–550 nm. Kinetic data were collect-
ed at an emission of 447 nm (GDP) or 445 nm (GTP) using 5 μMofmant
labelled nucleotide and a range of TbARL6 concentrations between 0.2
and 14 μM. Nucleotide exchange was studied by loading 5 μMof protein
with 5 μM mant labelled nucleotide for 5 min, then adding a 100-fold
excess of unlabelled nucleotide and collecting ﬂuorescence data every
10 s for a further 20 min. KD and κoff values were calculated by non-
linear regression using GraphPad Prism 4. Values shown represent the
mean from three independent experiments.
3. Results
3.1. T. brucei ARL6 orthologue
We ﬁrst identiﬁed the T. brucei ARL6 orthologue in a bioinformatic
search for downstream targets of the validated drug target myristoyl-
CoA:proteinN-myristoyltransferase (NMT) [19,22,35]. The constitutively
expressed TbARL6 gene encodes a protein of 21 kDa, which is predicted
to be N-myristoylated by virtue of the well-conserved N-terminal
consensus for N-myristoylation [36]. This is in contrast to ARL6 protein
sequences from other species including humans [37] which have an
N-terminal glycine residue but are not predicted by available algorithms
to be N-myristoylated. Similar to human BBS7, the TbARL6 protein does
not contain a nuclear localisation signal (NLS) but does have a leucine-
rich nuclear export signal (NES)motif (residues 139–147), using the pre-
diction software programs NLStradamus and NetNES 1.1 [38,39]. Using
the same programs, human Arl6 also has a predicted NES (residues
9–13) but no NLS.
3.2. TbARL6 associates with vesicles throughout the parasite body
In order to investigate subcellular localisation in T. brucei, we raised
a polyclonal antibody against full length recombinant protein. TbARL6
fused to a C-terminal His tag was readily expressed as a soluble protein
in E. coli and puriﬁed by afﬁnity puriﬁcation (Supplementary Fig. 1A).
Serum from a rabbit inoculated with recombinant TbARL6 detected a
band of approximately 22 kDa on immunoblots of total T. brucei lysates
(Supplementary Fig. 1B). Further, only the 22 kDa bandwas detected
in cell lysates by afﬁnity puriﬁed antibody (Supplementary Fig. 1B).
Although we cannot rule out the possibility that other ARF family
proteins could be detected by the antibody, the most closely related
protein to ARL6 encoded by the T. brucei genome is the Golgi protein
ARL1, which shares only 37% identity [22], while TbARF1 shares less
than 30% identity with TbARL6.
Immunoﬂuorescence assays using the antibody showed that ARL6
is present in a punctate distribution throughout the cell body in both
bloodstream form (BSF) and insect procyclic form (PCF) T. brucei and
has the same localisation in non-dividing and dividing cells (Fig. 1A).
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Fig. 1. Subcellular localisation of T. brucei ARL6. (A) Immunoﬂuorescence analysis of
T. brucei bloodstream form (BSF) line Lister 427 and insect procyclic form (PCF) line
449. Representative images of non-dividing (one nucleus and one kinetoplast) and
dividing (two nuclei and two kinetoplasts) cells are shown for each life cycle stage.
Cells were probed with anti-TbARL6 (red) and anti-α tubulin (green) and co-stained
with DAPI (blue). Bar, 5 μm. (B) Subcellular fractionation of TbARL6. Prepared subcellular
fractions from T. brucei BSF line Lister 427 (equivalent of 1×107 cells per lane) were
separated by SDS-PAGE, transferred to PVDF membrane and the resulting immunoblot
probed with anti-TbARL6, anti-NMT and anti-PFR1/2. T, total cell lysate, S, cytosolic S100
fraction, P, particulate membrane-containing P100 fraction, C, NP40-insoluble fraction
(containing cytoskeleton), F, NP40/1MNaCl fraction (containingﬂagella). (C–F) Transmis-
sion immuno-electron micrographs of BSF line Lister 427 probed with anti-TbARL6 and
detected with 10 nm colloidal gold conjugated goat-anti-rabbit. Fl, ﬂagellum; FP, ﬂagellar
pocket. Gold particles are indicated in (C) by black arrows. Bar, 200 nm (C, D) or 100 nm
(E, F).
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tent with the presence of a NES motif in the protein. There was no ob-
vious co-localisation between TbARL6 and the early endosomes, as
shown in cells incubated with ﬂuorescent ConA at 15 °C (Supplemen-
tary Fig. 2A). Localisation was investigated further by subcellular frac-
tionation, separating cells into cytosolic (S100) and particulate
membrane-containing (P100) fractions. The T. brucei cytoskeleton
and ﬂagella were also isolated by treatment with detergent and salt.
The NP40-insoluble fraction contains all components of the tubulin-based cytoskeleton but further extraction with salt solubilises the
subpellicular microtubules, therefore the NP40/1M NaCl-insoluble
fraction contains only the highly insoluble ﬂagella. TbARL6 protein
was found in the membrane-containing P100 fraction of BSF cell lysate
but not in the cytosolic S100 fraction, NP40-insoluble orNP40/1MNaCl-
insoluble fractions (Fig. 1B). This suggests that the protein associates
with cellular membranes but is not an integral part of the cytoskeleton,
consistent with its reported absence from the ﬂagellar proteome [28].
Intracellular localisation was studied at high resolution by transmission
immuno-electron microscopy (TiEM) (Fig. 1C–F). Endogenous TbARL6
was detected throughout the cell, particularly in association with
electron-dense vesicles of less than 100 nm diameter (Fig. 1C, E, and F)
and to a lesser extent with larger structures of approximately 200 nm
diameter (Fig. 1D). Negligible levels of gold labelling were detected in
negative-control samples without primary antibody (Supplementary
Fig. 3A).
When TbARL6 was overexpressed with a C-terminal myc tag, a
punctate pattern was also observed by immunoﬂuorescence, although
the foci were larger than for endogenous TbARL6 (Supplementary
Fig. 2B, top panel). Unlike endogenous TbARL6, themyc-tagged protein
showed some co-localisation with the early endosomes as visualised
using an antibody against T. brucei Rab5 (Supplementary Fig. 2B). This
may represent either mislocalisation due to the epitope tag or slower
trafﬁcking of the over-expressed protein. TiEM images show that the
tagged protein is associated with circular structures (Supplementary
Fig. 3) similar in morphology to the 200 nm diameter structures found
adjacent to a minor population of the endogenous protein (Fig. 1D
and data not shown). In contrast, a G2A mutant form of the protein
lacking the N-terminal glycine residue (the myristate acceptor) mis-
localised to the plasma membrane (Supplementary Fig. 2B). This
mutant isoform was readily expressed even in the absence of tetra-
cycline, showing some leakiness of the inducible promoter system.
Unlike thewild-type, the G2Amutant protein appeared to be a target
for proteolysis at its new site in the cell, as shown by immunoblot-
ting (Supplementary Fig. 2C). Another mutant form of TbARL6,
T21N (a critical residue for nucleotide binding found at the P-loop)
localised partially at the plasma membrane and partially in a punc-
tate distribution, a subpopulation of which co-localises with Rab5
(Supplementary Fig. 2B).
3.3. Evidence that TbARL6 is N-myristoylated
We tested the ability of TbARL6 to be N-myristoylated by metabolic
labelling of parasites with the alkynyl-myristate YnC12 [40], which acts
as a myristic acid analogue in cells and can be captured by copper-
catalysed click chemistry in combination with ﬂuorescent probes [29].
TbARL6 was captured from parasite lysates by immunoprecipitation
and labelling of YnC12-tagged proteins was carried out on-bead via a
click chemistry reaction between the alkyne functionality and ﬂuo-
rescent reagent Az-TB. Eluted proteins were analysed by SDS-PAGE
and immunoblotting as shown in Fig. 2. A strong ﬂuorescent signal
was observed at the predicted molecular weight of TbARL6 (approxi-
mately 21 kDa) following immunoprecipitation from T. brucei PCF and
BSF lysates labelled with YnC12 (Fig. 2A and B, in-gel and in-blot
ﬂuorescence), indicating that TbARL6 is labelled by this alkynyl my-
ristate analogue under the experimental conditions used. No signal
was detected following immunoprecipitation in the myristic acid con-
trol, in the total lysates prior to ﬂuorescent labelling or in the superna-
tant fraction following capture of TbARL6 to the beads. Immunoblotting
for TbARL6 conﬁrmed the presence of immunoprecipitated protein
in both YnC12 and myristic acid samples (Fig. 2C). A number of back-
ground bandswere observed, particularly in the PCF samples. However,
two speciﬁc bands were observed for TbARL6 in YnC12-labelled PCF
and BSF lysates following immunoprecipitation: the 21 kDa band and
an additional higher molecular weight band which likely corresponds
to the protein carrying the Az-TB label (mw of ~1000), as shown in
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Fig. 2.Myristate tagging and ﬂuorescent labelling to show N-myristoylation of TbARL6.
(A–C) T. brucei insect procyclic form (PCF) line 449 and bloodstream form (BSF) line
Lister 427 were metabolically labelled with myristic acid or the myristate analogue
YnC12. Immunoprecipitation was performed on cell lysates by the addition of rabbit
anti-TbARL6 and Protein A Sepharose beads, and captured proteins were subjected to
on-bead click labelling with the ﬂuorophore TAMRA. Samples were eluted, separated
by SDS-PAGE, transferred to PVDF membrane and ﬂuorescence was detected using
an Ettan DIGE scanner (GE Healthcare). In-gel (A) and in-blot (B) ﬂuorescence are
shown for PCF (left panels) and BSF (right panels) lysates. (C) Immunoblots were probed
with anti-TbARL6. 1, 2, Total lysate from myristic acid-labelled and YnC12-labelled cells
respectively (20% of fraction loaded), 3, 4, Elution from beads after immunoprecipitation
of lysate from myristic acid-labelled and YnC12-labelled cells respectively (100%), 5, 6,
Supernatant following immunoprecipitation for myristic-acid labelled and YnC12-labelled
cells respectively (20%).
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[41]. Comparison of the relative intensities of the two bands gives
an approximate tagging-labelling efﬁciency for TbARL6 of 50%
using this methodology.ARL6 
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A                      B
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Tub/DAPI           MergeD 
C  PFR/DAPI DIC 
 Merge 
Fig. 3. TbARL6 knockdown by RNA interference (A) Total cell lysates (5×106 cells/lane) fr
presence of tetracycline for 0–72 h were immunoblotted and probedwith anti-TbARL6 and ant
427 (wt) and transfected line 427/p2T7ARL6 (RNAi) in the absence and presence of tetracyclin
not visible. (C, D) Immunoﬂuorescence analysis of cell line 427/p2T7ARL6 grown in the presen
green) and co-stainedwith DAPI (blue). Bar, 5 μm. The bottom right panel in (C) is an enlarged v
rod length (E) and cell body length (F) in BSF parental line Lister 427 (wt) and cell line 427/p2T
horizontal lines (±SD) (n=100). Statistical analyses were performed using 1 way ANOV
(**=pb0.01, ***=pb0.001). All data shown are representative of experiments using at lea3.4. Depletion of TbARL6 by RNA interference
The functions of TbARL6were investigated by disrupting expression
in T. brucei BSF parasites using tetracycline-inducible RNA interference
(RNAi). TbARL6 protein levels were analysed in 6 independent RNAi
parasite clones by immunoblotting and densitometry using TbNMT as
a loading control (one representative example shown in Fig. 3A). The
protein level was reduced in induced cells but in all cases remained at
detectable levels throughout a 96 hour time course (Fig. 3A and data
not shown) demonstrating that RNAi knockdown was incomplete.
TbARL6 in the RNAi cell line shown in Fig. 3A decreased to 55% and
26% at 24 and 48 h post-induction respectively, compared to the level
in uninduced cells. TbARL6 protein persistently increased at either 72
or 96 h, indicative of the emergence of escape mutants resistant to tet-
racycline induction, a common feature of T. brucei RNAi studies [35,42].
An additional protein band (approximately 24 kDa) of unknown identi-
ty was also detected by the ARL6 antibody in some but not all clones at
later timepoints (Fig. 3A).
There was no evidence in any of the analysed parasite clones of
widespread cell death and no decrease in growth until late timepoints
(72 and 96 h) when there was a modest but statistically signiﬁcant
reduction in growth in induced cells compared to uninduced cells
(p=b0.001) (Fig. 3B). We cannot conclude that the observed defects
in growth late in the time course were due to a decrease in ARL6 pro-
tein because of the apparent emergence of rescue mutants but we are
able to surmise from our data that a moderate decrease in TbARL6 has
no effect on parasite growth within 48 h of induction.
Changes in cell morphology, in particular in assembly of the parasite
ﬂagellum, were investigated by immunoﬂuorescence and electron
microscopy. No obvious defects in cell morphology were observed 
F
Time (hours)
om BSF parental line Lister 427 (wt) and cell line 427/p2T7ARL6 (RNAi) grown in the
i-NMT to monitor equal sample loading. (B) Cumulative growth of BSF parental line Lister
e, monitored over a 5 day time course. Mean values (±SD) are plotted (n=3), error bars
ce of tetracycline for 24 h, probed with anti-PFR1/2 (C) or anti-α-tubulin (D) (shown in
iew (×2.5) of the regionmarked by a grey box in the bottom left panel. (E, F) Paraﬂagellar
7ARL6 (RNAi) grown in the presence of tetracycline for 0–72 h.Mean values are shown as
A. Asterisks represent statistical signiﬁcance compared to the wild-type (wt) sample
st 3 independent RNAi clones.
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except in a small minority of cells (b5%) which displayed axoneme
defects and a swollen ﬂagellar pocket (Supplementary Fig. 4C) com-
pared to an estimated b1% in uninduced cells.
The trypanosome ﬂagellum is composed of a canonical 9+2 micro-
tubular axoneme and the paraﬂagellar rod (PFR), a ﬁlamentous struc-
ture which runs parallel to the axoneme [43]. In order to analyse the
effects of TbARL6 knockdown on the ﬂagellum, the length of the PFR
wasmeasured in non-dividing cells (containing one nucleus and one ki-
netoplast, 1N1K) stained with DAPI and anti-PFR antibody prior to and
following the induction of RNAi. The PFR extends to the distal tip of
the ﬂagellum in induced cells and therefore can be used as a reliable
marker of ﬂagellum length (Fig. 3C). Body length was also measured
in non-dividing cells stained with DAPI and anti-α tubulin (Fig. 3D).
There was a modest but highly signiﬁcant decrease in PFR length at 24
and 48 h post-induction compared to wild-type and to uninduced cells
(p=b0.001) (Fig. 3E). Cells with shorter ﬂagella remained motile,
which is consistent with the observed normal growth described above.
Motility is known to be essential for viability of this parasite stage [28]
and any defects in this process would have resulted in cell death. WeA
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Fig. 4. Identiﬁcation of tubulin as an interacting partner of T. brucei ARL6. (A) PTP puriﬁcation
material (0.05% of fraction loaded), 2, 3, 4, Flowthrough andwashes of IgG Sepharose column (0
matrix (0.3%), 7, Flowthrough of StrataClean resin (2.9%), 9, Final eluate (100%). The ﬁnal eluted
as protein C-tagged TbARL6 (23 kDa),α/β-tubulin (50 kDa) and a keratin contaminant (~65 kD
by SDS-PAGE and either stained with Coomassie (Total) or transferred to PVDF (remaining pa
Biolabs). Blots were incubated in tubulin solution overnight, then probed with mouse mon
which speciﬁcally recognises acetylated α-tubulin (Acet α-Tub) or monoclonal antibody TUB
but without tubulin (−Tub+Ab) or without primary antibody (+Tub−Ab). (C) Microtubule
before ultracentrifugation. Soluble (S) and pellet (P) fractions were subjected to SDS-polyacryl
associated protein 2 (280 kDa, positive control), BSA, bovine serum albumin (68 kDa, negativealso observed a signiﬁcant decrease in PFR length in uninduced RNAi
cells compared to the parental line (p=b0.001), which may be due to
leaky expression of double-stranded RNA in the absence of tetracycline,
as described in previous studies [44]. Themean PFR lengthwas restored
at later time points, again suggesting the emergence of escape mutants.
Conversely, body length (including the region of the ﬂagellum exten-
ding beyond the anterior tip of the body)was onlymarginally decreased
in induced cells, with statistical signiﬁcance at 48h compared to wild-
type cells (p=b0.01) (Fig. 3F). Our data therefore suggest that amoder-
ate reduction in TbARL6 protein level resulted in a signiﬁcant decrease in
ﬂagellum length but otherwise did not seem to affect cell growth or
morphology.
We also tested the ability of BSF cells to establish an infection in a
mouse in vivo model (data not shown). TbARL6 RNAi was induced
with tetracycline for 4 h before infection and levels of parasitaemia
checked at 48 and 72 h post-infection. Parasite concentrations in the
blood were greater than 5×107/ml in mice infected with either the
parental or RNAi line by 72 h, indicating that parasites with a modest
reduction in ARL6 due to RNAi retain the ability to mount an infection
in vivo.B
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of TbARL6. Samples were separated by SDS-PAGE and stained with Coomassie. 1, Input
.05%, 0.2%, and 0.13%), 5 and 8, TEV protease eluate (1%), 6, Flowthrough of the anti-ProtC
fraction contains threemajor protein bands (marked by asterisks) whichwere identiﬁed
a). (B) Tubulin overlay assay. Puriﬁed recombinant proteins (1 μg per lane)were separated
nels). 1, Human Ras (R9894, Sigma), 2, TbARL6, 3, bovine serum albumin (New England
oclonal antibody TAT1 against α-tubulin (α-Tub), monoclonal antibody clone 6-11B-1
2.1 against β-tubulin (β-Tub). Control immunoblots were processed with TAT1 antibody
binding protein assay. Puriﬁed proteins were incubated with a microtubule preparation
amide electrophoresis and stained with Coomassie. MT, microtubules. MAP2, Microtubule
control). Corresponding protein marker positions are shown (kDa).
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As RNAi knockdown was incomplete, we attempted to generate a
BSF knockout line in which both alleles of the ARL6 gene were re-
placed by antibiotic resistance selection markers. Parasite lines withFig. 5. T. brucei ARL6 nucleotide interactions. Puriﬁed recombinant TbARL6 was used at
cence emission spectra of TbARL6 in the presence and absence of 6 M guanidine hydroch
and 10 mM MgCl2 in the presence and absence of 12.5 μM unlabelled GDP or GTP. (C, D)
and absence of TbARL6 protein. (E, F) Dissociation constants (Kd) for TbARL6 and mantGDP
from data obtained at a single emission wavelength (GDP, 445 nm, GTP, 447 nm) with a ﬁx
nucleotide exchange by TbARL6. Protein was prebound to mantGDP (G) or mantGTP (H), t
rescence was recorded over time and dissociation rate constants (κdiss) calculated by non
labelled nucleotide without the addition of unlabelled nucleotide. All data are representativeone deleted allele were readily produced but no double knockout
clones could be generated despite repeated transfections. Of a poten-
tial 192 clones (8×24 well plates) only two clones were successfully
cultivated, a 50-fold reduction in efﬁciency compared to transfections
to delete the ﬁrst allele of the gene. Both of these clones encoded the5 μM in 50 mM phosphate buffer unless otherwise stated. (A) Tryptophan ﬂuores-
loride. (B) Tryptophan ﬂuorescence emission spectra of TbARL6 in phosphate buffer
Mant ﬂuorescence emission spectra of mantGDP (C) and mantGTP (D) in the presence
(E) or mantGTP (F) were calculated by non-linear regression (one site speciﬁc binding)
ed concentration of nucleotide and a range of protein concentrations. (G, H) Guanine
hen mixed at 300 s with a large excess of unlabelled nucleotide. The decrease in ﬂuo-
-linear regression (one phase exponential decay). Controls represent protein and mant-
of at least 3 independent experiments.
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gene, suggesting gene ampliﬁcation events had occurred in these
cells. These results are in direct contrast to those obtained in our re-
cent study on a unrelated trypanosome gene DIP13. Both alleles of
this gene were successfully deleted from the T. brucei genome using
the same methods described here, with similar transfection efﬁcien-
cies observed for the ﬁrst and second transfections and no growth de-
fect was found in DIP13 null cells [45].
As an alternative approach, attempts were made to produce a
conditional knockout line in which both alleles of the ARL6 gene
were deleted in cells expressing TbARL6MYC under the control of a
tetracycline-inducible promoter. As before, single allele deletion
was achieved but no double knockout clones could be produced.
Southern blotting and PCR showed that the TbARL6 locus was still
present following correct integration of two antibiotic resistance
cassettes in 8 independent clones (data not shown), again indicating
that gene ampliﬁcation had occurred in these parasites. Therefore,
while moderate knockdown of the protein has no effect on cell
growth, attempts to delete both alleles of the gene have so far been
unsuccessful, resulting in either transfection failure or genetic
rearrangements. When put into context with current dogma in
kinetoplastid research, this suggests that the TbARL6 gene could in
fact be essential for viability and that the myc-tagged protein used
for complementation (which localises differently in the cell) is not
sufﬁcient to rescue cells. Further studies are therefore required to
determine whether TbARL6 is essential for viability in the parasite.
3.6. TbARL6 binds to tubulin
In order to ﬁnd the binding partners of TbARL6, we used a modiﬁed
version of tandem afﬁnity puriﬁcation (TAP), which involves fusion of
the protein to Protein A and Protein C epitopes (termed a PTP tag) [32]
to enable highly-speciﬁc puriﬁcation of protein complexes from crude
cell lysate. A construct encoding C-terminal PTP-tagged ARL6 was
inserted into the endogenous ARL6 locus of T. brucei procyclic parasites
to produce cells expressing tagged protein at endogenous levels. This
reduced the possibility of erroneous interactions due to overexpression
but necessitated the use of large volumes of cells in order to produce
detectable amounts of ﬁnal product. Following a series of afﬁnity puriﬁ-
cation steps, three proteins were detected in the ﬁnal eluate (Fig. 4A).
These were identiﬁed by mass spectrometry as TbARL6, α/β-tubulin
and a keratin contaminant, with identical results produced in four inde-
pendent biological replicates. As tubulin is highly abundant in trypano-
somes and often found as a contaminant in protein interaction studies,
additional studies were required to validate this protein as a binding
partner of TbARL6.
This was investigated further using a tubulin overlay assay
(Fig. 4B). Immunoblots of N-terminal His-tagged recombinant ARL6
(which cannot be N-myristoylated) and controls were incubated in
porcine tubulin solution before probing with anti-tubulin antibodies.
The presence of a 22 kDa band in the HisARL6 lane (Fig. 4B) clearly
showed binding of this protein toα-tubulin in vitro, whereas no signal
was produced in lanes containing either BSA or the small GTPase Ras.
The same band was also detected when blots were probed with anti-
bodies speciﬁc for acetylated α-tubulin and for β-tubulin. No bands
were visible in the absence of tubulin or primary antibody (Fig. 4B).
To further validate our ﬁndings, an in vitro microtubule binding
assay was performed in which puriﬁed proteins were incubated
with a preparation of polymerised tubulin prior to ultracentrifugation
(Fig. 4C). N-terminal His-tagged recombinant ARL6 was completely
soluble in the absence of microtubules but following incubation with
a microtubule preparation in the presence of guanine nucleotide
(Fig. 4C, right hand panel), a proportion of the TbARL6 protein
relocated to the insoluble fraction (36% of the protein in the presence
of GDP, 20%with GTP). Control lanes show that amajority of MAP2was
found in the insoluble fraction in the presence ofmicrotubules, whereasBSA which does not bind microtubules was detected exclusively in the
soluble fraction (Fig. 4C, left hand panel).
To summarise these ﬁndings, our data indicate that TbARL6 is a
tubulin-binding protein (with evidence from a range of techniques)
and has the ability to bind both unpolymerised tubulin and assembled
microtubules (albeit transiently or at lower afﬁnity than the MAP2
positive control). Further, these interactions are not dependent on
N-myristoylation or on speciﬁc nucleotide binding conformation of the
small GTPase.
We also tested the ability of TbARL6 to alter the in vitro polymer-
isation of tubulin in the presence of taxol, monitoring the increase in
turbidity as microtubules are produced, as described previously [34].
No signiﬁcant differences were seen in the presence or absence of re-
combinant TbARL6 (data not shown). Thus, while our data strongly
suggest interaction between TbARL6 and tubulin, the functional rele-
vance of this interaction in vivo will require further investigation.
3.7. TbARL6 nucleotide interactions
In addition to identifying protein binding partners of TbARL6, we
studied the nucleotide interactions of recombinant protein. To test the
folding integrity of puriﬁed protein, emission spectra were recorded for
TbARL6‐His either in phosphate buffer or following denaturation in 6 M
guanidinium hydrochloride. Denaturation caused an increase in trypto-
phan ﬂuorescence and a red shift of the emission maximum from
350 nm to 356 nm (Fig. 5A). This suggests that the protein has a hydro-
phobic core and is capable of folding in phosphate buffer in the absence
of Mg2+ or nucleotide. TbARL6 is therefore likely to be stable in a
nucleotide-free state. Intensity of the intrinsic ﬂuorescence of TbARL6‐His
decreased in the presence of GDP/GTP and 10 mMMgCl2 (Fig. 5B), with
GTP exerting the greatest effect. No change in ﬂuorescence was seen in
the absence of magnesium (data not shown) conﬁrming that nucleotide
binding, as for other Arf GTPases, is Mg2+‐dependent.
TbARL6‐His showed rapid binding with mant-labelled GDP and GTP,
causing an increase in the ﬂuorescence intensity of the nucleotides
(Fig. 5C and D). Fluorescence reached a plateau within 3 min (data
not shown) and remained relatively constant when measured at 10 s
intervals for 20 min (control samples in Fig. 5G and H). Equilibrium
binding constants were determined by titrating mant-labelled nucleo-
tides with increasing concentrations of protein and plotting the change
in ﬂuorescence (Fig. 5E and F). The dissociation constant (Kd) value of
each interaction was calculated by non-linear regression (one site spe-
ciﬁc binding) and comparedwith known values for other small GTPases
(Table 1) [46–52]. The Kd of TbARL6-His with GDP is 4.35 μM (±1.12)
and with GTP is 13.71 μM (±3.52). We attempted to corroborate
these data with unlabelled nucleotides by isothermal titration calorim-
etry (ITC) but the protein precipitated in response to the vigorous agita-
tion required.
Dissociation rate constants (κdiss) were measured by loading
TbARL6‐His with mant-labelled nucleotide, then adding a 100-fold
excess of unlabelled nucleotide and recording the decrease in ﬂuores-
cence as the mant-labelled molecules were displaced (Fig. 5G and H).
For both GDP and GTP, the resultant curves ﬁtted one-phase rather
than two-phase exponential decay, indicating a single dissociation
event. Similar values were produced when displacing the mant nucleo-
tides with either GDP or GTP (Fig. 5G and H and Table 1). The κdiss
for mantGDP was found to be 0.0076 s−1 (±0.0014) when displaced
with unlabelled GDP and 0.0093 s−1 (±0.0013) when displaced with
unlabelled GTP. The equivalent values for mantGTP were 0.0047
(±0.0006) with GDP and 0.0041 (±0.0007) with GTP.
3.8. Interaction between TbARL6 and the BBSome
Human Arl6 is now believed to interact with the BBSome complex
by directly binding to the BBS1 subunit [11,53]. To investigate whether
this interaction is conserved in kinetoplastids, an N-terminal myc
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Fig. 6. Association of TbARL6 with the BBSome. (A) Immunoﬂuorescence analysis of T. brucei
were incubated on ice with the lipophilic dye FM4-64 (red) to stain the ﬂagellar pocket prio
Bar, 5 μm. (B) Cells as in (A) above were grown in the absence (−Tet) or presence (+Tet) o
(red) and co-stained with DAPI. Bar, 5 μm. (C) Total cell lysates (1×107 cells/lane) from
pMYCBBS1 grown in the absence (−) or presence (+) of tetracycline for 24 h were immunob
(D) Cumulative growth of BSF transfected lines 427/pMYCBBS1 (BBS1) and 427/p2T7ARL6/pM
over a 5 day time course (mean±SD shown, n=3) with statistical analysis by 1 way ANOVA
Table 1
Guanine nucleotide binding and exchange kinetics of TbARL6. Dissociation constants
(Kd) and dissociation rate constants (κdiss) for the binding of N-terminal His-tagged
T. brucei ARL6 to mant guanine nucleotides (mGDP and mGTP), compared to values
obtained previously for other small GTPases using either mant or radioactive nucleotides
(shown in separate columns).
References: [1]M. Hanzal-Bayer, M. Linari, A.Wittinghofer, Properties of the interaction of
Arf-like protein 2 with PDEdelta, J Mol Biol, 350 (2005) 1074–1082. [2] M. Linari, M.
Hanzal-Bayer, J. Becker, The delta subunit of rod speciﬁc cyclic GMP phosphodiesterase,
PDE delta, interacts with the Arf-like protein Arl3 in a GTP speciﬁc manner, FEBS
Lett, 458 (1999) 55–59. [3] R.A. Kahn, A.G. Gilman, The protein cofactor necessary for
ADP-ribosylation of Gs by cholera toxin is itself a GTP binding protein, J Biol Chem, 261
(1986) 7906–7911. [4] D.D. Binns, B. Barylko, N. Grichine, M.A. Atkinson, M.K. Helms,
D.M. Jameson, J.F. Eccleston, J.P. Albanesi, Correlation between self-association modes
and GTPase activation of dynamin, J Protein Chem, 18 (1999) 277–290. [5] E.S. Burstein,
I.G. Macara, Interactions of the ras-like protein p25rab3A with Mg2+ and guanine
nucleotides, Biochem J, 282 ( Pt 2) (1992) 387–392. [6] B. Zhang, Y. Zhang, Z. Wang,
Y. Zheng, The role of Mg2+ cofactor in the guanine nucleotide exchange and GTP
hydrolysis reactions of Rho family GTP-binding proteins, J Biol Chem, 275 (2000)
25299–25307. [7] T. Terui, R.A. Kahn, P.A. Randazzo, Effects of acid phospholipids
on nucleotide exchange properties of ADP-ribosylation factor 1. Evidence for speciﬁc
interaction with phosphatidylinositol 4,5-bisphosphate, J Biol Chem, 269 (1994)
28130–28135.
mGDP mGTP GDP GTP GTPγS Ref.
Kd (μM)
TbARL6 4.354 13.710
Arl2 0.492 0.173 [1]
Arl3 0.240 48.000 [2]
Arf1 0.040 0.090 0.020 [3]
Dynamin 100.000 2.500 [4]
Rab3A 0.063 0.046 [5]
Cdc42 0.220 0.590 0.170 [6]
RhoA 0.110 0.480 0.160 [6]
Rac1 0.240 0.620 0.240 [6]
κdiss (s−1)
TbARL6 0.00757 0.00407
Arl2 0.02679 0.00716 [1]
Arl3 0.00017 0.03510 [2]
Arf1 0.00035 0.00170 [7]
Dynamin 93.00000 2.10000 [4]
Rab3A 0.00018 0.00040 [5]
Cdc42 0.01700 0.01500 [6]
RhoA 0.01500 0.01000 [6]
Rac1 0.02900 0.03100 [6]
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in bloodstream form parasites, as conﬁrmed by immunoﬂuorescence
(Fig. 6A–B) and immunoblotting (Fig. 6C). By 24 h post-induction
of MYCBBS1 expression, tagged protein was detected in a dense focus
at the posterior end of the cell. Co-localisation with the lipophilic dye
FM4-64 identiﬁed this as the ﬂagellar pocket (Fig. 6A). A striking differ-
ence in endogenous TbARL6 protein localisation can be seen following
the induction of BBS1 overexpression, with translocation from a
punctate pattern to a densely stained region that co-localises with
the MYCBBS1 protein at the posterior end of the parasite (Fig. 6B). In-
duction of MYCBBS1 expression had little effect on parasite division
until 72 and 96 h post-induction when a signiﬁcant reduction in cell
growth was detected compared to uninduced cells (p=b0.01).
When MYCBBS1 was expressed in the TbARL6 RNAi cell line, there was
a synergistic effect with a highly signiﬁcant decrease in growth by 72
and 96 h post-induction compared to uninduced cells, induction of
TbARL6 RNAi alone or MYCBBS1 expression alone (p=b0.001 in all
cases) and the presence of rounded cells (data not shown). These results
strongly suggest that the functional link between ARL6 and BBS1
observed in human cells is conserved in trypanosomes.
4. Discussion
4.1. Interactions of TbARL6
In this study, we show that the orthologue of Arl6 in trypanosomes
is N-myristoylated (unlike other Arl6 orthologues), is associated with
small vesicles throughout the parasite body and can associate with
tubulin. Knockdown of TbARL6 expression leads to a signiﬁcant de-
crease in ﬂagellum length but no motility defect. During the course of
these studies, a report was published describing the interaction be-
tween human Arl6 and the BBSome [11]. We were unable to detect
components of the BBSome in our afﬁnity puriﬁcation experiments
(Fig. 4A) but this was not surprising given that human Arl6 was not
co-puriﬁed with the other components of the BBSome in the original
study identifying this complex [12]. Instead, a GTP-locked Arl6 mutant
was later shown to bind to the BBSome [11] suggesting that binding
of the GTPase to these components may be transient and dependentmyc 
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of the highly conserved Gln 71 (discussed in Section 4.6), further inves-
tigation of relevant residues will be required before analysis of a GTP-
locked mutant is feasible. A recent study suggested that the interaction
between Arl6 and BBS1 may be regulated by the Arl6 N-terminus [53].
Further studies are required to determine if N-myristoylated TbARL6
retains the ability to bind BBS1. Moreover, the full complement of
Arl6 and TbARL6 interacting proteins and their roles in protein traf-
ﬁcking remain to be fully characterised. An earlier study used yeast
two-hybrid screening to identify six interacting partners of human
Arl6, including SEC61beta, a subunit of the heterotrimeric protein
conducting channel SEC61p and a molecule of unknown function,
Arl6 interacting protein 1 (Arl6ip) [54]. However, there are no clear
orthologues of any of these interacting proteins in trypanosomes
that are identiﬁable by computational analysis.
4.2. Loss of function of proteins associated with Bardet–Biedl syndrome
A range of model systems have been used to study loss of function
of the Bardet–Biedl associated proteins. With few exceptions, disrup-
tion of cilium function is the consistent phenotype regardless of
which BBS gene is targeted, leading to speciﬁc trafﬁcking or signalling
defects and downstream events depending on the model organism
studied. Unlike many of the IFT components, loss of BBS gene function
does not appear to be lethal [18,55]. Also, the assembly of cilia/ﬂagella
is still able to occur in the absence of speciﬁc subunits of the BBSome
complex in all eukaryotic systems studied to date, with the notable
exception of ﬂagellum production in the spermatozoa of knockout
mice [18,53,56–60]. Abnormalities in rhodopsin trafﬁcking in BBS
knockout mice leads to degeneration of photoreceptor cells [56,61,62],
a phenotype which can be prevented in Bbs4 knockout mice by adeno-
viral delivery of the Bbs4 gene [63]. Bbs3 (Arl6) knockout mice display
many of the characteristic features of Bardet–Biedl syndrome, including
retinal degeneration and male infertility but also have unique pheno-
types such as severe hydrocephalus, suggesting that the protein may
have roles in addition to BBSome recruitment [53]. Knockdown of BBS
genes (including BBS3) in zebraﬁsh causes delayed retrograde melano-
some transport and disruption of the Kupffer's Vesicle, a ﬂuid-ﬁlled
ciliated epithelial sac found in embryonic ﬁsh [58–60]. Changes
in Sonic Hedgehog (shh) expression are also observed, leading to alter-
ations in ﬁn bud patterning [59]. Conversely, speciﬁc knockdown of an
alternative transcript of BBS3 termed BBS3L does not produce this phe-
notype, instead resulting in retinal defects [64], therefore suggesting
that these two ARL6 variants have distinct non-overlapping functions.
BBSome insertionalmutants in C. reinhardtii can assemble normal length
motileﬂagella andhave normal IFT particle structure andmovement but
display a defect in phototaxis. This is due to an intraﬂagellar accumula-
tion of four putative signalling proteins, indicating that the BBSome
has a role in export of signalling proteins from the ﬂagellum [18].
In trypanosomes, we found that a modest knockdown of ARL6
does not kill the parasite but causes a signiﬁcant decrease in ﬂagellum
length, suggesting some evolutionary conservation in the function of
this protein. Flagellum motility and maintenance of ﬂagellar pocket
integrity are essential for viability of the host bloodstream form
(BSF) of the parasite and disruption of these by RNA interference in-
variably leads to cell death [28,65,66]. Partial knockdown of TbARL6
expression did not cause widespread cell death, unlike RNAi knock-
down of the related small GTPases ARL1 and ARF1 in T. brucei
[21,22]. Nevertheless, despite repeated attempts, we were unable to
generate a double knockout null line and further studies will be re-
quired to conﬁrm the full effects of ARL6 loss of function in this organ-
ism. Further, we found that overexpressed BBS1 in T. brucei localises
to the ﬂagellar pocket and results in a translocation of endogenous
TbARL6 to this site. A combination of BBS1 overexpression and knock-
down of ARL6 has a synergistic inhibitory effect on cell growth, indi-
cating a close link between ARL6 and the BBSome in trypanosomes.4.3. The BBSome and Rab8
BBS1 is able to directly bind Rabin8 [12] and a model has been
proposed in which the BBSome may be able to regulate activation of
the multifunctional small GTPase Rab8, leading to the sorting and
transport of cargo to the cilium [12,67] and potentially across the per-
iciliary barrier for conveyance to the IFT system [11]. However, while
Rab8 is found in almost all eukaryotes [68], the BBSome is restricted
to ciliated/ﬂagellated organisms [9]. Moreover, ﬂagellated protozoan
parasites have conserved BBSome subunits but lack a member of
the Rab8/Rab10/Rab13 clade [9,69], indicating that there is only a
partial overlap in functional mechanism between the BBSome and
Rab8, and that Rab8-independent BBSome processes must exist, at
least in protozoa.
4.4. Localisation of ARL6 and the BBSome
Human Arl6 localises to the distal end of basal bodies and to primary
cilium membranes [11,70] and the orthologue of this protein has been
detected in the ﬂagellar proteome of C. reinhardtii [71] but not in
similar studies of T. brucei procyclic and BSF parasites [28,45].
Human BBSome components have been detected in two pools,
localising to centriolar satellites and inside the primary cilium. Afﬁnity
puriﬁcation techniques have shown that the subunit BBS4 interacts
directly with PCM1, the core component of the centriolar satellites,
which may act as a chaperone to prevent coat assembly before it is
required. In contrast, the BBSome found within the primary cilium
is dissociated from PCM1 and associates instead with GTP-bound
Arl6 [11,12]. PCM1 and centriolar satellites are not conserved in pro-
tozoans, therefore a different mechanism may be required for safe
transport of the BBSome components from their site of synthesis
(as yet unidentiﬁed) to the ﬂagellar pocket or other locations in the
cell. Our data suggest that endogenous TbARL6 is associated with
small vesicles throughout the parasite body and we speculate that
TbARL6 could mediate delivery of the BBSome components on
these vesicles.
4.5. TbARL6 localisation and tubulin association
Our protein interaction studies identiﬁed tubulin as a potential
binding partner of TbARL6, independent of N-myristoylation or nu-
cleotide binding status. This suggests a possible association of ARL6-
positive vesicles with cytoplasmic microtubules to facilitate transport
to the ﬂagellar pocket, although these structures have not yet been
visualised in T. brucei [72]. No signiﬁcant co-localisation was found
between endogenous TbARL6 and the endosomes but myc-tagged
ARL6 partially co-localises with the early endosomal marker Rab5 in
parasites, signifying either mislocalisation due to the epitope tag or
abnormal accumulation of overexpressed protein at this stage due
to saturation of the transport mechanism. Although the N-terminus
is known to be critical for N-myristoylated Arf/Arl function, blocking
the C-terminus by epitope-tagging may also be detrimental to protein
function [27,73]. It is interesting to note that the G2A mutant of
TbARL6 shows a subcellular localisation consistent with binding to
the subpellicular microtubules at the plasma membrane. We hypo-
thesise that N-myristoylation could provide the switch required for
additional interactions to occur which limit potential association
with tubulin and thus enable TbARL6 to reach its correct vesicular
localisation. In the absence of this modiﬁcation, TbARL6 may instead
accumulate at a “default” localisation in the region with the highest
tubulin concentration, that of the subpellicular cortex underlying the
plasma membrane [74]. Endogenous TbARL6 has not been detected
in detergent-insoluble cell extracts (which contain the cytoskeleton),
showing that any association with microtubules is probably transient.
An intriguing alternative hypothesis to direct microtubule binding is
that tubulin may be a cargo molecule of ARL6-positive vesicles. It has
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and axoneme, including tubulin, may be transported via association
with Golgi-derived vesicles which exocytose with the basal body and
then the ciliary membrane [75]. Tubulin has been identiﬁed in vesicles
destined for the cilium and may in fact peripherally associate with
the outside of vesicles prior to exocytosis with the ciliary membrane
[75], in a similar mechanism to that described for F-actin delivery on
endosome-derived vesicles to ingressing cleavage furrows during cyto-
kinesis [76].
Two other proteins in the Arf family, Arl7 and Gie/Arl8, have been
shown to date to bind directly with tubulin [77,78]. Arl7 binds to α-
tubulin [77], shows upregulated expression in response to cholesterol
loading and has been implicated in transport of apolipoprotein AI-
dependent cholesterol export [77,79]. Gie/Arl8 is essential for equal
segregation of chromosomes in mammalian cells and Drosophila
[78]. Like T. brucei ARL6, Gie is able to bind to both α- and β-
tubulin, independent of the nucleotide-binding status of the GTPase
[78]. The ability to bind tubulin is retained in mutant forms of Gie1
(Arl8B) lacking the Switch I or Switch II effector binding domains,
suggesting that tubulin is a binding partner rather than an effector
or regulator molecule. Other members of the Arf family, Arl2 and
Arl3, have roles in microtubule-related processes but these are not
believed to require a direct interaction with tubulin. GDP-bound
Arl2 binds to tubulin cofactor D, preventing the disassembly of micro-
tubules [2]. The orthologue of Arl2 in T. brucei is required for cleavage
furrow ingression during cytokinesis and knockdown causes the pro-
duction of multinucleated cells [27]. Arl3 is closely related to Arl2 and
is able to bind all Arl2 effector proteins with the exception of cofactor
D [80]. Arl3 has an additional set of interacting partners, human reti-
nal gene 4 (HRG4/UNC119) and retinitis pigmentosa 2 (RP2), with
which it can form a ternary complex [81]. Similar to Arl6, Arl3 has
been detected on primary cilia in human photoreceptor cells [82,83]
and Arl3 knockout mice develop photoreceptor degeneration [84].
Kinetoplastids have three putative Arl3 orthologues [22], of which
one, termed ARL-3A, has been studied in detail. Disruption of ARL-
3A function in Leishmania by expression of either GTP-locked or
GDP-locked forms and in T. brucei by RNAi knockdown causes signif-
icant shortening of ﬂagella without loss of motility [85–87], as found
here with knockdown of T. brucei ARL6. ARL-3A in Leishmania
amazonensis is found in a punctate pattern [87] and may therefore
have a vesicular localisation similar to that for TbARL6. Recent studies
have shown that Arf proteins can act in synergy to produce an activa-
tion cascade, as shown previously for Rabs [88], with a minor popula-
tion of GTP-bound activated Arf6 or Arl4 binding to the PH domain of
the Arno GEF to enhance binding of Arf1 to the Sec7 domain, thus
triggering Arf1 activation [89]. Our data suggest that T. brucei ARL6
has spatial and functional similarities to ARL-3A and there may con-
ceivably be an association between the two proteins, either in func-
tion or in triggering activation.
4.6. Guanine nucleotide binding properties of TbARL6
As a small GTPase, the nucleotide binding properties of Arl6 will
almost certainly be critical for its function. As a reﬂection of this,
many of the Arl6 mutations described in BBS patients are missense
mutations of the highly conserved amino acids required for guanine
nucleotide association [90]. Expression of GDP- and GTP-locked vari-
ants of Arl6 in a human cell line does not alter cell growth or gross
morphology but signiﬁcantly changes the proportion of cells
possessing cilia and the length of assembled cilia. Overexpression of
wild-type Arl6 causes an increase in Wnt signalling, as measured by
the level of β-catenin transcriptional activity, but expression of
nucleotide-locked variants of Arl6 has no effect on this response
[70]. The amino acid residues Thr 31 and Gln 71 (Arf1 numbering)
are highly conserved in nearly all Ras-like small GTPases, with critical
roles in GTP binding and hydrolysis, respectively. Sequence alignmentof putative Arl6 orthologues (Supplementary Fig. 5) shows that while
Thr 31 is conserved in the kinetoplastid orthologues (except in T.
cruzi), the equivalent residue of Gln 71 in Arf1, is substituted by ala-
nine in the parasite Arl6 sequences (residue 63). Gln 71 is also absent
from the larger GTPase dynamin, which has the ability to self-
assemble into higher order structures, resulting in active-site confor-
mational changes which in turn stimulate GTP hydrolysis [91].
In light of this information, we investigated the ability of recombi-
nant His-tagged TbARL6 to bind nucleotides using tryptophan and
ﬂuorescence spectroscopy. There are two tryptophan residues in
TbARL6, one of which resides in the Switch II effector binding domain.
Our data indicate that nucleotide binding causes a local conforma-
tional change in this region which partially quenches ﬂuorescence,
as shown for Rab5 [92]. Previous studies have shown that Arf1 re-
quires the presence of lipids and Mg2+ for nucleotide binding and is
unstable in vitro in a nucleotide-free state. Arf1 has a very high afﬁn-
ity for guanine nucleotides (nanomolar range) and the exchange rate
is extremely slow [48]. In contrast, the related protein Arl2 is stable in
a nucleotide-free state and has low afﬁnity for nucleotides due partly
to a rapid exchange rate [46]. We conclude from our data that
TbARL6-His protein is stable in the absence of nucleotides and is able
to bind guanine nucleotides with low afﬁnity in the absence of lipids,
with relatively rapid exchange rates. Therefore, the protein appears to
be similar in terms of nucleotide binding characteristics to Arl2. Both
TbARL6 and dynamin lack the equivalent residue of Gln 71 in Arf1, an
amino acid shown to be crucial for GTP hydrolysis. As both of these
proteins also exhibit low afﬁnity for GTP, it is possible that this resi-
due may have a role in modulating nucleotide afﬁnity in small
GTPases. Alternatively, the His tag may exert some inhibitory effects
or TbARL6 may require other factors such as membrane lipids for op-
timal nucleotide association.
4.7. Concluding remarks
In conclusion, we have investigated the functions of the Arl6
orthologue in T. brucei, a divergent lower eukaryote which encodes
the BBSome components but lacks a Rab8 orthologue. It is yet to be
proven that the BBSome has a role in transporting cargo to the ﬂagel-
lum in kinetoplastid parasites but the functional analysis of T. brucei
ARL6 presented here suggests that this mechanism is fundamentally
conserved and required for ﬂagellum extension. We propose that
there is a conserved functional association between the BBSome and
ARL6 in T. brucei which is required for ﬂagellar extension in a Rab8
null background. Remarkable recent evidence has shown that the
scope of the intraﬂagellar transport system is not restricted to that
of transport within the ﬂagellum. One of the IFT components, IFT20,
has a dynamic localisation in photoreceptor cells, moving between
the Golgi and the primary cilium, therefore providing a potential
transport link between the endomembrane system and the IFT ma-
chinery [93]. Considering the widespread distribution of ARL6 in try-
panosomes, we cannot rule out the possibility that this protein may
also have a role linking transport between multiple sites in the para-
site. Further studies will be required to elucidate the exact molecular
mechanisms of ARL6 and related BBSome functions in trypanosomes
and other eukaryotic cells.
Supplementary data related to this article can be found online at
http://dx.doi.org/10.1016/j.bbamcr.2012.05.007.
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